This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,896.80 firm fixed-price delivery order is for the supply of Eliquis 2.5 mg tablets, a medication used to treat and prevent blood clots. The contract has a completion date of December 17, 2024.
The award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen, as the prime contractor, is responsible for delivering the Eliquis tablets to the designated place of performance in Conshohocken, Pennsylvania. This contract supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through the DLA's procurement of essential pharmaceutical and medical supplies.
Generated 3/17/25, 9:58 AM